Spread of streptococcus pneumoniae serotype 8-st63 multidrug-resistant recombinant clone, Spain

Emerging Infectious Diseases

Volumn 20, Issue 11, 2014, Pages 1848-1856

  Ardanuy, Carmen ^a,b   De La Campa, Adela G ^b,c   García, Ernesto ^b,c   Fenoll, AsuncióN ^b   Calatayud, Laura ^a,b   Cercenado, Emilia ^b,d   Pérez Trallero, Emilio ^b,e   Bouza, Emilio ^b,d   Liñares, Josefina ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e HOSPITAL DONOSTIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN BINDING PROTEIN 1A; PENICILLIN BINDING PROTEIN 2A; PENICILLIN BINDING PROTEIN 2B; PENICILLIN BINDING PROTEIN 2X; PENICILLIN DERIVATIVE; PROTEIN PARC; PROTEIN PARE; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CODON;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BROTH DILUTION; CHILD; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE; GENE REARRANGEMENT; GENETIC RECOMBINATION; GENETIC TRANSFORMATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE GENE; MULTIDRUG RESISTANT SEROTYPE 8 ST63; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PNEUMOCOCCAL INFECTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ALIGNMENT; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; BACTERIAL GENOME; CHEMISTRY; CLASSIFICATION; CODON; GENE ORDER; GENETIC POLYMORPHISM; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; MOLECULAR TYPING; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PNEUMOCOCCAL INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CHILD; CODON; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE ORDER; GENOME, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; PHENOTYPE; PNEUMOCOCCAL INFECTIONS; POLYMORPHISM, GENETIC; RECOMBINATION, GENETIC; SEROGROUP; SPAIN; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84908117150     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2011.131215     Document Type: Article

References (32)

1. Calix JJ, Porambo RJ, Brady AM, Larson TR, Yother J, Abeygunwardana C, et al. Biochemical, genetic and serological characterization of two capsule subtypes among Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype. J Biol Chem. 2012;287:27885-94. http://dx.doi.org/10.1074/jbc. M112.380451
2. Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, Maiden MC, et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis. 2006;194:682-8. http://dx.doi.org/10.1086/505710
3. Sjöström K, Spindler C, Ortqvist A, Kalin M, Sandgren A, Kühlmann-Berenzon S, et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis. 2006;42:451-9. http://dx.doi.org/10.1086/499242
4. Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA, Rolo D, et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7- valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis. 2009;48:57-64. http://dx.doi.org/10.1086/594125
5. Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog. 2007;3:e1628-36. http://dx.doi.org/10.1371/ journal.ppat.0030168
6. Coffey TJ, Daniels M, Enright MC, Spratt BG. Serotype 14 variants of the Spanish penicillin-resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA-pbp1a region. Microbiology. 1999;145:2023-31. http://dx.doi. org/10.1099/13500872-145-8-2023
7. Fenoll A, Jado I, Vicioso D, Pérez A, Casal J. Evolution of Streptococcus pneumoniae: serotypes and antibiotic resistance in Spain. Update (1990 to 1996). J Clin Microbiol. 1998;36:3447-54
8. Fenoll A, Granizo JL, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47:1012-20. http://dx.doi.org/10.1128/JCM.01454-08
9. McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC, George R, et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol. 2001;39:2565-71. http://dx.doi.org/10.1128/JCM.39.7.2565-2571.2001
10. Sá-Leão R, Tomasz A, de Lencastre H. Multilocus sequence typing of Streptococcus pneumoniae clones with unusual drug resistance patterns: genetic backgrounds and relatedness to other epidemic clones. J Infect Dis. 2001;184:1206-10. http://dx.doi. org/10.1086/323663
11. Clinical and Laboratory Standard Institute. Methods for dilution antimicrobial susceptibility test for bacteria that growth aerobically. 8th ed. Vol. 29. Approved standard. CLSI/NCCLS document M7-A8. Wayne (PA): The Institute; 2009
12. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement. Vol. 31. CLSI/NCCLS document M100-S21. Wayne (PA): The Institute; 2011
13. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology. 1998;144:3049-60. http://dx.doi.org/10.1099/00221287-144-11-3049
14. du Plessis M, Bingen E, Klugman KP. Analysis of penicillinbinding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin. Antimicrob Agents hemother. 2002;46:2349-57. http://dx.doi.org/10.1128/AAC.46. 8.2349-2357. 2002
15. Gherardi G, Whitney CG, Facklam RR, Beall B. Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2bpbp2x- dhf restriction profiles. J Infect Dis. 2000;181:216-29. http:// dx.doi.org/10.1086/315194
16. Calatayud L, Ardanuy C, Tubau F, Rolo D, Grau I, Pallarés R, et al. Serotype and genotype replacement among macrolide-resistant invasive pneumococci in adults: mechanisms of resistance and association with different transposons. J Clin Microbiol. 2010;48:1310- 6. http://dx.doi.org/10.1128/JCM.01868-09
17. Alonso R, Galimand M, Courvalin P. An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone- resistant Streptococcus pneumoniae. J Antimicrob Chemother. 2004;53:682-3. http://dx.doi.org/10.1093/jac/dkh147
18. Pan XS, Ambler J, Mehtar S, Fisher LM. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996;40:2321-6
19. de la Campa AG, Balsalobre L, Ardanuy C, Fenoll A, Pérez- Trallero E, Liñares J. Spanish Pneumococcal Infection Study Network G03/103. Fluoroquinolone resistance in penicillinresistant Streptococcus pneumoniae clones, Spain. Emerg Infect Dis. 2004;10:1751-9. http://dx.doi.org/10.3201/eid1010.040382
20. Dopazo J, Mendoza A, Herrero J, Caldara F, Humbert Y, Friedli L, et al. Annotated draft genomic sequence from a Streptococcus pneumoniae type 19F clinical isolate. Microb Drug Resist. 2001;7:99- 125. http://dx.doi.org/10.1089/10766290152044995
21. Sanz JC, Cercenado E, Marín M, Ramos B, Ardanuy C, Rodríguez- Avial I, et al. Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients. Clin Microbiol Infect. 2011;17:1094- 8. http://dx.doi.org/10.1111/j.1469-0691.2011.03495.x
22. de la Campa AG, Ardanuy C, Balsalobre L, Pérez-Trallero E, Marimón JM, Fenoll A, et al. Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, pain. Emerg Infect Dis. 2009;15:905-11. http://dx.doi.org/10.3201/eid1506.080684
23. Sá-Leão R, Pinto F, Aguiar S, Nunes S, Carriço JA, Frazão N, et al. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol. 2011;49:1369-75. http://dx.doi. org/10.1128/JCM.01763-10
24. Coffey TJ, Dowson CG, Daniels M, Zhou J, Martin C, Spratt BG, et al. Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol Microbiol. 1991;5:2255-60. http:// dx.doi.org/10.1111/j.1365-2958.1991.tb02155.x
25. Wyres KL, Lambertsen LM, Croucher NJ, McGee L, von Gottberg A, Liñares J, et al. Pneumococcal capsular switching: a historical perspective. J Infect Dis. 2013;207:439-49. http://dx.doi. org/10.1093/infdis/jis703
26. Pernot L, Chesnel L, Le Gouellec A, Croize J, Vernet T, Dideberg O, et al. A PBP2X from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to β-lactam antibiotics. J Biol Chem. 2004;279:16463-70. http:// dx.doi.org/10.1074/jbc.M313492200
27. Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis. 2008;197:1016-27. http://dx.doi.org/10.1086/ 528996
28. Ardanuy C, Rolo D, Fenoll A, Tarragó D, Calatayud L, Liñares J. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother. 2009;64:507-10. http://dx.doi.org/10.1093/jac/dkp210
29. Wolter N, du Plessis M, von Gottberg A, de Gouveia L, Klugman KP. Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa. J Clin Microbiol. 2009;47:1319-24. http://dx.doi.org/10.1128/ JCM.02280-08
30. Ho P-L, Que T-L, Chiu SS, Yung RWH, Ng T-K, Tsang DNC, et al. Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001. Emerg Infect Dis. 2004;10:1250-7. http://dx.doi.org/10.3201/eid1007.030612
31. de Cueto M, Rodríguez JM, Soriano MJ, López-Cerero L, Venero J, Pascual A. Fatal levofloxacin failure in treatment of a bacteremic patient infected with Streptococcus pneumoniae with a preexisting parC mutation. J Clin Microbiol. 2008;46:1558-60. http://dx.doi. org/10.1128/JCM.02066-07
32. Campos J, Ferech M, Lázaro E, de Abajo F, Oteo J, Stephens P, et al. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother. 2007;60:698-701. http://dx.doi.org/10.1093/ jac/dkm248